image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Babcock - Defence firm with contracted orders covering 70% sales on PE of just 9.2

April 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BAB
  • Price:
  • 331p
To borrow from Winston Churchill’s famous quip, “meeting jaw to jaw is better than war” and he had plenty of experience of both - but events surrounding Russia’s invasion of Ukraine show that this strategy is not always possible. The world was a different place four weeks ago but the invasion is leading to a step change in defence spending and reminds us of the biggest lesson from the Cold War: the power of deterrence.One old TMI favourite worth revisiting is Babcock, a defence contractor with expertise maintaining UK nuclear submarines and surface ships as well as new build work including the Queen Elizabeth class aircraft carriers and new Type 31 frigates. Babcock was a main write-up back in September 2005 at just 178p and the sh ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author